BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND NOTCH1, TAN1, P46531, 4851, ENSG00000148400, hN1 AND Prognosis
189 results:

  • 1. Integrated analysis of transcriptome and genome variations in pediatric T cell acute lymphoblastic leukemia: data from north Indian tertiary care center.
    Singh M; Sharma P; Bhatia P; Trehan A; Thakur R; Sreedharanunni S
    BMC Cancer; 2024 Mar; 24(1):325. PubMed ID: 38459434
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Clinical and molecular biological characterization of patients with accelerated chronic lymphocytic leukemia].
    Zhou ZY; Dai LMJ; Sha YQ; Qiu TL; Qin SC; Miao Y; Xia Y; Wu W; Tang HN; Xu W; Li JY; Zhu HY
    Zhonghua Xue Ye Xue Za Zhi; 2023 Nov; 44(11):917-923. PubMed ID: 38185521
    [No Abstract]    [Full Text] [Related]  

  • 3. Chronic Lymphocytic leukemia IGHV Somatic Hypermutation Detection by Targeted Capture Next-Generation Sequencing.
    Grants JM; May C; Bridgers J; Huang S; Gillis S; Meissner B; Boyle M; Ben-Neriah S; Hung S; Duns G; Hilton L; Gerrie AS; Marra M; Kridel R; Sabatini PJB; Steidl C; Scott DW; Karsan A
    Clin Chem; 2024 Jan; 70(1):273-284. PubMed ID: 38175592
    [TBL] [Abstract] [Full Text] [Related]  

  • 4.
    Choi YJ; Min YK; Lee ST; Choi JR; Shin S
    Ann Lab Med; 2024 Jul; 44(4):335-342. PubMed ID: 38145892
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. NOTCH pathway mutation contributes to inferior prognosis in HBV-infected chronic lymphocytic leukemia.
    Shang CY; Bei LY; Wu JZ; Sheng HR; Yin H; Liang JH; Wang L; Li JY; Li Y; Xu W
    Ann Hematol; 2024 Mar; 103(3):833-841. PubMed ID: 37993586
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The clinical features and prognostic implications of PTPN11 mutation in adult patients with acute myeloid leukemia in China.
    Yang J; Zhao L; Wu Y; Niu T; Gong Y; Chen X; Huang X; Liu J; Dai Y; Ma H
    Cancer Med; 2023 Dec; 12(23):21111-21117. PubMed ID: 37937729
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Molecular characteristics in Chinese with chronic lymphocytic leukemia by next-generation sequencing: A single-center retrospective analysis.
    Cao Y; Chen Y; Tao T; Gong Y; Xu C; Cen J; Shen H; Pan J; Chen S; Yao L
    Int J Lab Hematol; 2023 Dec; 45(6):908-916. PubMed ID: 37551448
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Clinical characteristics of 11 patients with chronic lymphocytic leukemia with t (14;19) (q32;q13)].
    Cui CH; Chang YN; Zhou J; Li CW; Wang HJ; Sun Q; Jia YJ; Li QH; Wang TY; Qiu LG; Yi SH
    Zhonghua Xue Ye Xue Za Zhi; 2023 May; 44(5):418-423. PubMed ID: 37550193
    [No Abstract]    [Full Text] [Related]  

  • 9. Anlotinib exerts an anti-T-cell acute lymphoblastic leukemia effect in vitro and in vivo.
    Zhang X; Geng L; Yang L; Wang Y; Zou Z; Zhang Y; Xu H; Lei H; Cao Y; Wu Y; Gu W; Zhou L
    Cell Signal; 2023 Oct; 110():110837. PubMed ID: 37544636
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Characteristics of Molecular Genetic Mutations and Their Correlation with prognosis in Adolescent and Adult Patients with Acute Lymphoblastic leukemia.
    Sun X; Liu X; Li Y; Shi X; Li Y; Tan R; Jiang Y; Sui X; Ge X; Xu H; Wang X; Fang X
    Oncology; 2024; 102(1):85-98. PubMed ID: 37437551
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Outlier Expression of Isoforms by Targeted or Total RNA Sequencing Identifies Clinically Significant Genomic Variants in Hematolymphoid Tumors.
    Tsai HK; Gogakos T; Lip V; Tsai JM; Li YD; Fisch AS; Weiss J; Yang W; Grimmett L; DiToro D; Schaefer EJ; Lindsley RC; Tran TH; Caron M; Langlois S; Sinnett D; Pikman Y; Nardi V; Kim AS; Silverman LB; Harris MH
    J Mol Diagn; 2023 Sep; 25(9):665-681. PubMed ID: 37419244
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Targeted therapy and immunotherapy for T cell acute lymphoblastic leukemia/lymphoma.
    Huang YH; Wan CL; Dai HP; Xue SL
    Ann Hematol; 2023 Aug; 102(8):2001-2013. PubMed ID: 37227492
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. MicroRNA-143 acts as a tumor suppressor through Musashi-2/DLL1/notch1 and Musashi-2/Snail1/MMPs axes in acute myeloid leukemia.
    Li F; Han Y; Chen R; Jiang Y; Chen C; Wang X; Zhou J; Xu Q; Jiang S; Zhang S; Yu K; Zhang S
    J Transl Med; 2023 May; 21(1):309. PubMed ID: 37149661
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Genetic and Clinical Characteristics of Korean Chronic Lymphocytic leukemia Patients with High Frequencies of
    Ahn A; Kim HS; Kim TY; Lee JM; Kang D; Yu H; Lee CY; Kim Y; Eom KS; Kim M
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834590
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Clinical Study on the Relationship between Gene Mutation Profile and prognosis in Pediatric Acute Lymphocyte leukemia].
    Chen Y; Qi SS; Ding LL; DU Y; Song N; Wang Z; Yang L; Sun M; Xiong H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):17-24. PubMed ID: 36765471
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Spectrum and clinical features of gene mutations in Chinese pediatric acute lymphoblastic leukemia.
    Shen D; Liu L; Xu X; Song H; Zhang J; Xu W; Zhao F; Liang J; Liao C; Wang Y; Xia T; Wang C; Lou F; Cao S; Qin J; Tang Y
    BMC Pediatr; 2023 Feb; 23(1):62. PubMed ID: 36739388
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Clonality relatedness and molecular characteristics of Richter transformation].
    Sha YQ; Jiang R; Miao Y; Qiu TL; Qin SC; Qiu JY; Mi HL; Wu W; Qiao C; Wu YJ; Xia Y; Wang L; Fan L; Xu W; Li JY; Zhu HY
    Zhonghua Xue Ye Xue Za Zhi; 2022 Oct; 43(10):841-847. PubMed ID: 36709198
    [No Abstract]    [Full Text] [Related]  

  • 18. [Clinical analysis of 20 cases of small B lymphocyte proliferative disease with t (14;19) (q32;q13)].
    Yang H; Guo R; Shi Y; Qiao C; Wu YJ; Fan L; Xu W; Miao KR; Li JY; Qiu HR
    Zhonghua Xue Ye Xue Za Zhi; 2022 Aug; 43(8):674-679. PubMed ID: 36709153
    [No Abstract]    [Full Text] [Related]  

  • 19. Notch Partners in the Long Journey of T-ALL Pathogenesis.
    Toribio ML; González-García S
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674902
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Exploring the pharmacological mechanisms of Shuanghuanglian against T-cell acute lymphoblastic leukaemia through network pharmacology combined with molecular docking and experimental validation.
    Yang Y; Yang Y; Shen Y; Liu J; Zeng Y; Wei C; Liu C; Pan Y; Guo Q; Zhong F; Guo L; Liu W
    Pharm Biol; 2023 Dec; 61(1):259-270. PubMed ID: 36656546
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 10.